Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

Sanofi hands over R&D site, $310M to Evotec in a cross-cutting alliance
Fierce Biotech
Wed, 12/3/14 - 12:16 pm
Tags:
Sanofi, R&D, Evotec
Sanofi SA (SNY) Gets FDA Nod For Priftin Tablets To Treat Latent TB Infection
Bidness Etc.
Tue, 12/2/14 - 09:00 am
Tags:
Sanofi, FDA, Priftin, tuberculosis
POZEN Inc. and Sanofi US Mutually Agree to Terminate U.S. Partnership for PA8140/PA32540
Yahoo
Mon, 12/1/14 - 09:02 am
Tags:
Pozen, Sanofi, Yosprala
French firm signals 'new era' in malaria fight
The Local, France
Sat, 11/22/14 - 11:18 am
Tags:
Sanofi, antimalarial, malaria, artemisinin
MannKind’s Afrezza Remains in Sanofi’s Plans, RBC Says
Barron's
Fri, 11/21/14 - 03:07 pm
Tags:
MannKind, inhaled insulin, Afrezza, diabetes, Sanofi
Europe gives green light to AbbVie hepatitis C medicine, others
Yahoo/Reuters
Fri, 11/21/14 - 08:11 am
Tags:
Europe, AbbVie, hepatitis C, dasabuvir, Sanofi, eliglustat, Novartis, secukinumab, Merck, Vorapaxar, Boehringer Ingelheim, nintedanib
Biotech's 3 Most Influential CEOs
Motley Fool
Thu, 11/20/14 - 10:54 am
Tags:
biotech, Ivax, Teva Pharmaceutical, Phillip Frost, OPKO Health, Chris Viehbacher, Sanofi, Gilead Sciences, John C. Martin
Sanofi Forecast for Flat Diabetes Sales Disappoints Investors
Bloomberg
Thu, 11/20/14 - 10:41 am
Tags:
Sanofi, diabetes
Sanofi makes case for experimental drugs in pipeline
CNBC
Wed, 11/19/14 - 05:30 pm
Tags:
Sanofi
Sanofi Said to Consider Smith & Nephew, Takeda for CEO
Bloomberg
Wed, 11/19/14 - 10:11 am
Tags:
Sanofi, Pharma CEOs, Takeda, Smith & Nephew
Regeneron drug highly effective for those who can't take statins: study
Reuters
Tue, 11/18/14 - 03:49 pm
Tags:
Regeneron, statins, Sanofi, alirocumab
Sanofi tags newly OK'd MS drug Lemtrada at $158K, ready to tout head-to-head Rebif data
Fierce Pharma Marketing
Tue, 11/18/14 - 11:01 am
Tags:
Sanofi, Lemtrada, MS, multiple sclerosis
Sanofi execs prep their pitch on a post-Viehbacher R&D strategy
Fierce Biotech
Thu, 11/13/14 - 12:59 pm
Tags:
Sanofi, R&D
Sanofi's dual-action biotech asthma drug performs well in test
Yahoo/Reuters
Tue, 11/11/14 - 08:57 am
Tags:
Sanofi, asthma, dupilumab, Regeneron
Sanofi SA (SNY) Stock On A Decline Since Ousting Of CEO Chris Viehbacher
Bidness Etc.
Mon, 11/10/14 - 11:16 am
Tags:
Sanofi, Chris Viehbacher
Sanofi, armed with more strong PhIII dengue data, sets sights on 2015 rollout
Fierce Vaccines
Thu, 11/6/14 - 11:44 am
Tags:
Sanofi, dengue, vaccines
Memo to Sanofi: AstraZeneca’s Soriot Says He’s Australian
Bloomberg
Thu, 11/6/14 - 08:20 am
Tags:
Sanofi, Pascal Soriot, Pharma CEOs
Sanofi revamps 'underperforming' U.S. sales team under new diabetes chief
Fierce Pharma Marketing
Wed, 11/5/14 - 01:55 pm
Tags:
Sanofi, reorganization, drug reps, diabetes
Digesting Sanofi's Two Pieces Of News- Lantus' Challenging Outlook And The CEO Dismissal
Seeking Alpha
Wed, 11/5/14 - 08:11 am
Tags:
Sanofi, Lantus, Chris Viehbacher
Diabetes Analyst: Sanofi CEO's Firing May Spell Trouble for MannKind Afrezza Partnership
TheStreet.com
Tue, 11/4/14 - 02:23 pm
Tags:
diabetes, Sanofi, Chris Viehbacher

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.